Effects of antiplatelet components of tomato extract on platelet function in vitro and ex vivo: A time-course cannulation study in healthy humans

American Journal of Clinical Nutrition

Volumn 84, Issue 3, 2006, Pages 570-579

  O'Kennedy, Niamh ^a,b   Crosbie, Lynn ^a   Van Lieshout, Machteld ^b   Broom, John I ^c   Webb, David J ^d   Duttaroy, Asim K ^e  

^a PROVEXIS PLC   (United Kingdom)

^b ROWETT RESEARCH INSTITUTE   (United Kingdom)

^c ROBERT GORDON UNIVERSITY   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

Cardiovascular disease; Natural antiplatelet agents; Platelet; Thrombosis; Tomato

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; COLLAGEN; FIBRINOGEN RECEPTOR; THROMBIN; BETA3 INTEGRIN; FIBRINOLYTIC AGENT; GLYCOPROTEIN IIB; PLANT EXTRACT;

ADULT; ARTICLE; BLOOD CLOTTING; CANNULATION; DIET SUPPLEMENTATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; MALE; NORMAL HUMAN; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; TOMATO; AGED; BLOOD; BLOOD CLOTTING PARAMETERS; CARDIOVASCULAR DISEASE; CATHETERIZATION; CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; KINETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; THROMBOSIS;

LYCOPERSICON ESCULENTUM;

ADULT; AGED; BLOOD COAGULATION; CARDIOVASCULAR DISEASES; CATHETERIZATION; CROSS-OVER STUDIES; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INTEGRIN BETA3; KINETICS; LYCOPERSICON ESCULENTUM; MALE; MIDDLE AGED; PLANT EXTRACTS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; PLATELET MEMBRANE GLYCOPROTEIN IIB; THROMBOSIS;

EID: 33750139716     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/84.3.570     Document Type: Article

References (45)

1. Heart disease and stroke statistics - 2003 update. Dallas, TX: American Heart Association, 2003.
2. Gartside P, Glueck C. The important role of modifiable dietary and behavioral characteristics in the causation and prevention of coronary heart disease hospitalization and mortality: the prospective NHANES I follow-up study. J Am Coll Nutr 1995;14:71-9.
3. Hu F, Rimm E, Stampfer M, Ascherio A, Spiegelman D, Willet W. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr 2000;72:912-21.
4. Joshipura K, Hu F, Manson J, et al. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med 2001;134:1106-14.
5. Kerver J, Yang E, Bianchi L, Song W. Dietary patterns associated with risk factors for cardiovascular disease in healthy US adults. Am J Clin Nutr 2003;78:1103-10.
6. Kris-Etherton P, Harris W, Appel I. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Scientific statement of the American Heart Association Nutrition Committee. Circulation 2002;106:2747-57.
7. Hertog M, Feskens E, Hollman P, Katan M, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11.
8. Rahman K. Historical perspective on garlic and cardiovascular disease. J Nutr 2001;131:977S-9S.
9. Bucher H, Hengstler P, Schindler C, Meier G. n-3 Polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 2002;112:298-304.
10. Osganian S, Stampfer M, Rimm E, Spiegelman D, Manson J, Willet W. Dietary carotenoids and risk of coronary artery disease in women. Am J Clin Nutr 2003;77:1390-9.
11. Dutta-Roy AK. Dietary components and human platelet activity. Platelets 2002;13:67-75.
12. Wilcox J, Catignani G, Lazarus S. Tomatoes and cardiovascular health. Crit Rev Food Sci Nutr 2003;43:1-18.
13. Weisburger J. Evaluation of evidence on the role of tomato products in disease prevention. Proc Soc Exp Biol Med 1998;218:140-3.
14. Agarwal S, Rao A. Tomato lycopene and low density lipoprotein oxidation: a human dietary intervention study. Lipids 1998;33:981-4.
15. Arab L, Steck S. Lycopene and cardiovascular disease. Am J Clin Nutr 2000;71(suppl):1691S-5S.
16. Rissanen T, Voutilainen S, Nyyssonen K, Salonen J. Lycopene, atherosclerosis and coronary heart disease. Exp Biol Med 2002;227:900-7.
17. Agarwal S, Rao A. Tomato lycopene and its role in human health and chronic diseases. Can Med Assoc J 2000;163:739-44.
18. Sesso H, Liu S, Gaziano J, Buring J. Dietary lycopene, tomato-based food products and cardiovascular disease in women. J Nutr 2003;133:2336-41.
19. De Lorgeril M, Salen P, Martin J, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999;99:779-85.
20. Kohlmeier L, Kark J, Gomez-Garcia E, et al. Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 1997;146:618-26.
21. Rissanen T, Voutilainen S, Nyyssonen K, Salonen R, Kaplan G, Salonen J. Serum lycopene concentrations and carotid atherosclerosis: the Kuopio Ischaemic Heart Disease Risk Factor Study. Am J Clin Nutr 2003;77:133-8.
22. Hak A, Stampfer M, Campos H, et al. Plasma carotenoids and tocopherols and risk of myocardial infarction in a low-risk population of US male physicians. Circulation 2003;108:802-7.
23. Dutta-Roy A, Crosbie L, Gordon M. Effects of tomato extract on human platelet aggregation in vitro. Platelets 2001;12:218-27.
24. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001;104:365-72.
25. Zaman A, Helft G, Worthley S, Badimon J. The role of plaque rupture and thrombosis in coronary artery disease. Atherosclerosis 2000;149:251-66.
26. Ruggeri Z. Mechanisms initiating platelet thrombus formation. Thromb Haemost 1997;78:611-6.
27. Osterud B. A global view on the role of monocytes and platelets in atherogenesis. Thromb Res 1997;85:1-22.
28. Dutta-Roy A, Gordon M, Kelly C, et al. Inhibitory effect of Gingko biloba extract on human platelet aggregation. Platelets 1999;10:298-305.
29. Storey R, May J, Wilcox R, Heptinstall S. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Thromb Haemost 1999;82:1307-11.
30. Yamamoto J, Taka T, Yamada K, et al. Tomatoes have natural antithrombotic effects. Br J Nutr 2003;90:1031-8.
31. Lazarus S, Garg M. Tomato extract inhibits human platelet aggregation in vitro without increasing basal cAMP levels. Int J Food Sci Nutr 2004;249-56.
32. Rein D, Paglieroni T, Pearson D, et al. Cocoa and wine polyphenols modulate platelet activation and function. J Nutr 2000;130:2120S-6S.
33. Murphy K, Chronopoulos A, Singh I, et al. Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 2003;77:1466-73.
34. Janssen K, Mensink R, Cox F, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998;67:255-62.
35. Shattil S, Kashiwagi H, Pampori N. Integrin signalling: the platelet paradigm. Blood 1998;91:2645-57.
36. Phillips DR, Agin PP. Platelet membrane defects in Glanzmann's thrombasthenia. Evidence for decreased amounts of two major glycoproteins. J Clin Invest 1977;60:535-45.
37. Tozer E, Hughes P, Loftus J. Ligand binding and affinity modulation of integrins. Biochem Cell Biol 1996;74:785-98.
38. IIbβ3 conformations. J Biol Chem 1999;274:12945-9.
39. IIbβ 3-mediated outside-in signal transduction, thromboxane A2, and adenosine diphosphate in collagen-induced platelet aggregation. Blood 2003;101:2646-51.
40. Stenberg P, McEver R, Shuman M, Jacques Y, Bainton D. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol 1985;101:880-6.
41. Hamburger S, McEver R. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990;75:550-4.
42. McEver R, Moore K, Cummings R. Leukocyte trafficking mediated by selectin-carbohyhdrate interactions. J Biol Chem 1995;270:11025-8.
43. Furie B, Furie B, Flaumenhaft R. A journey with platelet P-selectin: the molecular basis of granule secretion, signalling and cell adhesion. Thromb Haemost 2001;86:214-21.
44. Undar L, Akkoc N, Alakavuklar M, Cehreli C, Undar L. Flow cytometric analysis of circadian changes in platelet activation using anti-GMP-140 monoclonal antibody. Chronobiol Int 1999;16:335-42.
45. Mores N, Martire M, Pistritto G, et al. Platelet alpha 2-adrenoceptors and diurnal changes of platelet aggregability in hypertensive patients. J Hypertens 1994;12:939-45.